Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianela Barros

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
ESC Heart Failure|October 8, 2024
Safety and efficacy of up to 60 h of iv istaroxime in pre-cardiogenic shock patients: Design of the SEISMiC trialJan Biegus, Alexander Mebazaa, Marco Metra, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 1, 2025
Safety and efficacy intravenous istaroxime up to 60 hours for patients with pre-cardiogenic shockJan Biegus, Alexandre Mebazaa, Marco Metra, et al.
ESC Heart Failure|October 14, 2025
Haemodynamic effects of istaroxime in SCAI stage B HF-related cardiogenic shock: Insights from the SEISMiC trialMatteo Pagnesi, Gad Cotter, Beth Davison, et al.
Journal of the American College of Cardiology|May 31, 2023
Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection FractionMatteo Pagnesi, Marco Metra, Alain Cohen-Solal, et al.
JAMA Cardiology|December 27, 2023
Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical TrialGad Cotter, Benjamin Deniau, Beth Davison, et al.
Journal of Cardiac Failure|October 11, 2023
Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF TrialDaniela Tomasoni, Beth Davison, Marianna Adamo, et al.
European Heart Journal|May 22, 2023
NT-proBNP and high intensity care for acute heart failure: the STRONG-HF trialMarianna Adamo, Matteo Pagnesi, Alexandre Mebazaa, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 11, 2024
Insights on prevalence and incidence of anemia and rapid up-titration of oral heart failure treatment from the STRONG-HF studyJelena Čelutkienė, Kamilė Čerlinskaitė-Bajorė, Gad Cotter, et al.
Journal of the American College of Cardiology|July 17, 2024
Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HFJan Biegus, Alexandre Mebazaa, Beth Davison, et al.
American Heart Journal|May 13, 2024
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trialMattia Arrigo, Beth Davison, Christopher Edwards, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
ESC Heart Failure|October 8, 2024
Safety and efficacy of up to 60 h of iv istaroxime in pre-cardiogenic shock patients: Design of the SEISMiC trialJan Biegus, Alexander Mebazaa, Marco Metra, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 1, 2025
Safety and efficacy intravenous istaroxime up to 60 hours for patients with pre-cardiogenic shockJan Biegus, Alexandre Mebazaa, Marco Metra, et al.
ESC Heart Failure|October 14, 2025
Haemodynamic effects of istaroxime in SCAI stage B HF-related cardiogenic shock: Insights from the SEISMiC trialMatteo Pagnesi, Gad Cotter, Beth Davison, et al.
Journal of the American College of Cardiology|May 31, 2023
Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection FractionMatteo Pagnesi, Marco Metra, Alain Cohen-Solal, et al.
JAMA Cardiology|December 27, 2023
Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical TrialGad Cotter, Benjamin Deniau, Beth Davison, et al.
Journal of Cardiac Failure|October 11, 2023
Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF TrialDaniela Tomasoni, Beth Davison, Marianna Adamo, et al.
European Heart Journal|May 22, 2023
NT-proBNP and high intensity care for acute heart failure: the STRONG-HF trialMarianna Adamo, Matteo Pagnesi, Alexandre Mebazaa, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 11, 2024
Insights on prevalence and incidence of anemia and rapid up-titration of oral heart failure treatment from the STRONG-HF studyJelena Čelutkienė, Kamilė Čerlinskaitė-Bajorė, Gad Cotter, et al.
Journal of the American College of Cardiology|July 17, 2024
Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HFJan Biegus, Alexandre Mebazaa, Beth Davison, et al.
American Heart Journal|May 13, 2024
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trialMattia Arrigo, Beth Davison, Christopher Edwards, et al.
Pageof 2